Brokerages predict that ReneSola Ltd (NYSE:SOL – Get Rating) will report ($0.06) earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have provided estimates for ReneSola’s earnings, with estimates ranging from ($0.06) to ($0.05). ReneSola reported earnings of $0.05 per share during the same quarter last year, which would suggest a […]
Zacks Investment Research downgraded shares of Lucid Diagnostics (NASDAQ:LUCD – Get Rating) from a hold rating to a sell rating in a research report report published on Thursday, Zacks.com reports. According to Zacks, “Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in […]